Mezzanine & Preferred Equity in Boston, MA

Boston anchors its commercial real estate fundamentals on the deepest concentration of academic and medical institutions in the country, with MIT, Harvard, Boston University, Northeastern, and Tufts collectively driving technology licensing, venture formation, and a life sciences spinout pipeline that has made Cambridge and the Seaport District two of the most competitive lab and R&D leasing markets globally. Massachusetts General Hospital, Brigham and Women's, Dana-Farber Cancer Institute, and Boston Children's Hospital sustain a medical office and research facility demand that extends well beyond the Longwood Medical Area into suburban submarkets like Waltham, where established biotech campuses house companies ranging from early-stage spinouts to large-cap pharmaceutical operators. Lab conversion and ground-up lab construction have reshaped what was once conventional office inventory in East Cambridge and the Seaport, with triple-net rents for purpose-built wet lab space running at multiples of the broader office market, though rising construction costs and a pullback in early-stage venture funding since 2022 have introduced meaningful lease-up risk for speculative deliveries. Multifamily demand across Somerville, Quincy, and the Inner Belt corridor remains structurally undersupplied relative to household formation, a dynamic produced by a combination of the state's Chapter 40B affordability overlay, contentious local zoning approval processes in most inner-ring communities, and a persistently high-wage workforce that sustains rent levels even through economic softening. Industrial and last-mile logistics in the South Shore and Route 128 arc continue to tighten as redevelopment pressure converts older flex inventory to higher uses, leaving distribution operators with few large-block options inside the urban core.